Skip to content

Safety and hypoglycemic Efficacy of Bitter melon (Momordica charantin L.) capsules in pre - diabetes patients

Safety and hypoglycemic Efficacy of Bitter melon (Momordica charantin L.) capsules in pre - diabetes patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180222004
Enrollment
220
Registered
2018-02-22
Start date
2016-02-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre diabetes Pre diabetes

Interventions

Bitter cucumber capsule 500 mg take 2 capsule 2 time a day before meal for 6 months,Placebo capsule 500 mg take 2 capsule 2 time a day before meal for 6 months
Active Comparator Drug,Placebo Comparator Drug
Bitter cucumber capsule,Placebo

Sponsors

ARDA
Lead Sponsor
Chao Phya Abhaibhubejhr hospital foundation
Collaborator

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1 Fasting plasma glucose 100-125mg /dl or glycated hemoglobin (HbA1c) 5.7-6.4% 2 Age 30-60 years old

Exclusion criteria

Exclusion criteria: 1 Serum creatinine higher than 1.8 mg/dL 2 Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin or alkaline phosphatase higher than 2.5 times of the upper normal range 3 Hemogloblin lower than 10 g/dL 4 Heart disease (Angina, heart failure with left ventricular hypertrophy (LVH)) 5 Pregnant and lactating women 6 Patients was present sulfonylureas, metformin, thiazolidinediones, glitinides, alphaglucosidase inhibitors or insulin use prior to study enrollment participation in another clinical trial within 30 days of screening

Design outcomes

Primary

MeasureTime frame
Fasting plasma glucose 6 month Fasting plasma glucose level

Secondary

MeasureTime frame
Liver function test 6 month Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) level

Countries

Thailand

Contacts

Public ContactNatdanai Musigavong

Unaffiliated

mnatdanai@hotmail.com037211289

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026